Equities: running out of puff?
As equities head ever higher, can valuations survive a slowing recovery as momentum in areas such as earnings and economic growth peak? In such uncertain times, it may be time to consider a focus on quality and growth opportunities.
- The “bull case” for US equities looks promising as fresh highs are reached
- Despite the upbeat mood, gains appear likely to be more of a struggle as positive surprises are tougher to come by and recovery momentum slows
- Sectors linked to climate change, new technologies and healthcare seem to have strong growth potential whatever shape the pandemic takes next
- At this stage of the recovery, neutral levels of cyclical exposure seem more appropriate, while targeting quality rather than value opportunities
- Portfolio diversification and active management looks particularly appealing at the moment.
The “bull case” for US equities looks promising as earnings for the first three months of the year lift consensus full-year 2021 earnings per share (EPS) estimates to $180 from $170 for the S&P 500.
Caution called for
The outlook for equities may be promising, however gains appear likely to be more of a struggle as surprises on the upside may be tougher to come by. Equities tend to respond to momentum, rather than to their absolute level. Momentum might slow this year on many fronts as “peaks”, such as for earnings and global economic growth, come and go. While this need not signal a correction for equities, short-term upside might be limited.
The economic growth rate may soon slow
Economic momentum is the first of the peaks on the horizon. China and the US, the two largest economies, look particularly susceptible to this one.
Chinese gross domestic product (GDP) climbed by 18.3% year-on-year in the first quarter. That said, comparison with the first quarter of last year was made easier given the sharp, sudden contraction in output then, as the effects of COVID-19 surfaced. Indeed, the growth rate slowed to 0.6% on a quarter-on-quarter basis, suggesting a slowing recovery.
In the US, the ISM services index of activity climbed to a 63.7 high in March, pointing to a healthy economy. While the economy may improve in the next couple of months, as activity picks up, the rate of progress is likely to slow as output returns to pre-coronavirus levels.
What next for monetary policy?
Central banks’ accommodative responses to the pandemic have underpinned the charge in equities seen since March 2020. By injecting record liquidity into financial markets and keeping interest rates low, monetary policy has helped to lift valuations and risk appetite. That said, excluding a resurging pandemic, it’s difficult to envisage more dovish policy this year. While a tighter stance may be at least some quarters away, the liquidity impulse is likely to slow.
Have government spending commitments reached their limits?
Like central banks, governments took a “whatever it takes” approach to the pandemic response. Investors have a better understanding now of the size and scope of Joe Biden’s administration’s policy plans. Importantly, additional government spending isn’t unequivocally positive for equities, given spending offsets in the form of higher tax rates.
In the UK, the government set a precedent this year when announcing corporate tax rates would rise from 2023. In Europe, there may be some wiggle room, but timing is an issue as member states are yet to receive money from the €750bn recovery package that was approved last year.
Peak earnings growth
There appears little question that company earnings can keep growing, including in the short term, supporting the rationale for allocating to equities. The consensus expects year-on-year S&P 500 EPS growth of 34%, 57%, 21% and 15%, respectively, in the four quarters of this year. However, growth looks set to slow from the third quarter and this momentum shift may challenge valuations.
Other peaks: vaccinations and inflation
Two other variables, the pace of vaccinations and inflation, look like peaking too this year. First, the economic benefits flowing from vaccinating more people, especially in the developed world, may slip on reaching herd immunity. Second, inflationary pressures might peak in the summer. In turn, this suggests that the recovery could be running out of puff.
Upbeat mood for now
The state of the recovery is not the only factor driving sentiment. As the recovery loses momentum, other factors could pick up. First, this year’s generally buoyant investor mood and healthy equity inflows are not backed up by positioning, which seems relatively limited still. Second, in a two-track recovery, China, the US and the UK might have, or be near, recovered, but growth in continental Europe and most emerging markets lags. This could spark a second leg in the recovery.
While much of the focus for investors in the last year has been on the pandemic, areas of the economy can grow strongly, aside from COVID-19 trends. Sectors linked to climate change, new technologies (such as automation and artificial intelligence) and healthcare are cases in point.
Time to be invested and diversified
The long-term outlook remains encouraging and supportive for equity investors. With uncertainty to the fore, appropriate diversification through active management appears essential. However, because of the nearing momentum peaks, it may be time to reduce cyclical exposure to more neutral levels. This, combined with a focus on quality, may place portfolios well for what could be a bumpier road ahead.
Investments can fall as well as rise in value. Your capital or the income generated from your investment may be at risk.
- Has been prepared by Barclays Private Bank and is provided for information purposes only
- Is not research nor a product of the Barclays Research department. Any views expressed in this communication may differ from those of the Barclays Research department
- All opinions and estimates are given as of the date of this communication and are subject to change. Barclays Private Bank is not obliged to inform recipients of this communication of any change to such opinions or estimates
- Is general in nature and does not take into account any specific investment objectives, financial situation or particular needs of any particular person
- Does not constitute an offer, an invitation or a recommendation to enter into any product or service and does not constitute investment advice, solicitation to buy or sell securities and/or a personal recommendation. Any entry into any product or service requires Barclays’ subsequent formal agreement which will be subject to internal approvals and execution of binding documents
- Is confidential and is for the benefit of the recipient. No part of it may be reproduced, distributed or transmitted without the prior written permission of Barclays Private Bank
- Has not been reviewed or approved by any regulatory authority.
Any past or simulated past performance including back-testing, modelling or scenario analysis, or future projections contained in this communication is no indication as to future performance. No representation is made as to the accuracy of the assumptions made in this communication, or completeness of, any modelling, scenario analysis or back-testing. The value of any investment may also fluctuate as a result of market changes.
Barclays is a full service bank. In the normal course of offering products and services, Barclays may act in several capacities and simultaneously, giving rise to potential conflicts of interest which may impact the performance of the products.
Where information in this communication has been obtained from third party sources, we believe those sources to be reliable but we do not guarantee the information’s accuracy and you should note that it may be incomplete or condensed.
Neither Barclays nor any of its directors, officers, employees, representatives or agents, accepts any liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this communication or its contents or reliance on the information contained herein, except to the extent this would be prohibited by law or regulation. Law or regulation in certain countries may restrict the manner of distribution of this communication and the availability of the products and services, and persons who come into possession of this publication are required to inform themselves of and observe such restrictions.
You have sole responsibility for the management of your tax and legal affairs including making any applicable filings and payments and complying with any applicable laws and regulations. We have not and will not provide you with tax or legal advice and recommend that you obtain independent tax and legal advice tailored to your individual circumstances.
THIS COMMUNICATION IS PROVIDED FOR INFORMATION PURPOSES ONLY AND IS SUBJECT TO CHANGE. IT IS INDICATIVE ONLY AND IS NOT BINDING.